KRAS and pancreatic neoplasm: Interestingly, results revealed a higher percentage of KRAS-wt status (67%), as opposite to canonical KRAS-mut pancreatic cancer, as also confirmed by a comprehensive systematic review coupled with a comparative analysis with large datasets [16].